The case for adjuvant chemotherapy in pancreatic cancer
Authors:
- Asma SultanaASAsma Sultana
- Susannah ShoreSSSusannah Shore
- Deborah StockenDSDeborah Stocken
- John NeoptolemosJNJohn Neoptolemos
- 30 April 2006
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 20 (2) , 383-401
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancerSurgery, 2004
- Current standards of surgery for pancreatic cancerBritish Journal of Surgery, 2004
- Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancerSurgical Oncology Clinics of North America, 2004
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004
- Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic unitsBritish Journal of Surgery, 1997
- Regional Celiac Artery Infusion as Adjuvant Treatment after Pancreatic Cancer ResectionDigestion, 1997
- Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological studyBritish Journal of Surgery, 1995
- Results of resection for cancer of the exocrine pancreas: A study from the French Association of SurgeryBritish Journal of Surgery, 1994
- Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre studyEuropean Journal of Cancer, 1993